CDH17 and breast cancer: Treatment with NO decreases the level of cadherin-E and cell adhesion, indicating that NO signaling is involved in the epithelial-to-mesenchymal transition (EMT) in breast cancer [21,31], and EMT is considered the main driving force of the metastatic cascade.